Indivumed Biobank plays a meaningful role in the ICGC/TCGA Pan-Cancer Project to Decipher the Cancer Genome

Indivumed is delighted to announce that our unique, high-quality tissue biobank played a meaningful role in the success of the Pan-Cancer Project, the largest, most comprehensive analysis of cancer genomes to date.

The Pan-Cancer Project is an international collaboration seeking to identify common patterns of mutation in more than 2,600 whole cancer genomes from the International Cancer Genome Consortium (ICGC) and the Cancer Genome Atlas (TCGA). The end result of the project, published today in Nature  is a reflection of the work of more than 1,300 scientists and clinicians from 37 countries and more than 70 institutions. The study significantly improves our fundamental understanding of cancer and signposts new directions for its diagnosis and treatment.

Indivumed’s unique tissue biobank is the foundation for IndivuType, the first global multiomics cancer database. In addition to whole genome data, the IndivuType database goes beyond genomics to house whole transcriptome, proteomics and phosphoproteomics data collected annually from several thousand patients around the globe.